Filing Details

Accession Number:
0001250853-13-000111
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-07 20:20:46
Reporting Period:
2013-11-05
Filing Date:
2013-11-07
Accepted Time:
2013-11-07 20:20:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Lion Biotechnologies Inc. LBIO Arrangement Of Transportation Of Freight & Cargo (4731) 753254381
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1550588 Manish Singh 21900 Burbank Boulevard, 3Rd Floor
Woodland Hills CA 91367
President & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-05 607,500 $0.00 1,813,500 No 4 A Direct
Common Stock Acquisiton 2013-11-05 125,000 $2.00 1,938,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Acquisiton 2013-11-05 125,000 $0.00 125,000 $2.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
125,000 2013-11-05 2018-11-05 No 4 A Direct
Footnotes
  1. These shares were issued to the reporting person pursuant to a merger agreement between Lion Biotechnologies, Inc. and Genesis Biopharma, Inc. dated July 24, 2013 whereby upon the completion of a financing within 12 months following the merger, additional shares would be issued to the reporting person. The Issuer completed a financing on November 5, 2013.
  2. These warrant shares were acquired in a recent offering by the Issuer of common stock and warrants whereby a purchase of each share of common stock included a warrant exercisable for one share of common stock at $2.50 per share.